Skip Nav Destination
BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution
Acta Haematol (2015) 134 (4): 248–254.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Katia B. Pagnano
- Ana Ines Varela
- Carolina Pavlovsky
- Israel Bendit
- Vaneuza A. M. Funke
- Virginia Abello Polo
Current Hematologic Malignancy Reports (2021) 16 (5): 440.
- Katia B.B. Pagnano
- Ana Beatriz P. Lopes
- Eliana C. Miranda
- Márcia T. Delamain
- Gislaine O. Duarte
- Bruna R.V. Rodrigues
- Valquiria M.O. Povoa
- Graziele C.P. Furlin
- Jessica C. Vianna
- Matheus A.S. da Silva
- Carmino A De Souza
- Erich V De Paula
American Journal of Hematology (2020) 95 (12)
- Katia Borgia Barbosa Pagnano
- Eliana Cristina Miranda
- Márcia Torresan Delamain
- Gislaine Oliveira Duarte
- Erich Vinicius de Paula
- Irene Lorand-Metze
- Carmino Antonio de Souza
Clinical Lymphoma Myeloma and Leukemia (2017) 17 (11): 728.
- Katia Borgia Barbosa Pagnano
Revista Brasileira de Hematologia e Hemoterapia (2017) 39 (3): 197.
- KATIA BORGIA BARBOSA PAGNANO
- MÁRCIA TORRESAN DELAMAIN
- MARIANA MUNARI MAGNUS
- JOSÉ VASSALLO
- CARMINO ANTONIO DE SOUZA
- DAIANE DE ALMEIDA
- IRENE LORAND-METZE
Oncology Letters (2016) 12 (1): 485.
- Rony Schaffel
Acta Haematologica (2015) 134 (4): 246.